Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Raymond Woosley MD, PhD

Raymond L. Woosley MD, PhD

President & Chairman of the Board for CredibleMeds Worldwide; Professor of Medicine & Pharmacology, University of Arizona College of Medicine, Phoenix, Arizona; President, AZCERT

Raymond L. Woosley, M.D., Ph.D. is the founding President and Chairman of the Board for CredibleMeds Worldwide, a non-profit organization dedicated to safe use of medications. He is Emeritus Professor of Medicine and Pharmacology at the University of Arizona College of Medicine in Phoenix, Az and a member of the Sarver Heart Center.

Dr. Woosley received his medical degree from the University of Miami, FL, his doctorate in pharmacology from the University of Louisville, KY, and his bachelor's degree from Western Kentucky University. After an internship and residency in internal medicine, he completed a fellowship in clinical pharmacology at Vanderbilt University before joining the faculty and rising to the rank of Professor of Medicine and Pharmacology.

In 1988, Dr. Woosley was appointed Chairman of the Department of Pharmacology at Georgetown University Medical Center in Washington, D.C. In 2001, Dr. Woosley joined the faculty at The University of Arizona as Vice President of the Arizona Health Sciences Center and the Dean of the College of Medicine. In 2005, he founded Critical Path Institute (C-Path), an independent, non-profit organization created jointly by the U.S. Food and Drug Administration (FDA) and the University of Arizona to help implement the FDA’s Critical Path Initiative and accelerate drug and diagnostic development.

Dr. Woosley’s research has been reported in more than 280 peer-reviewed publications and serve as the basis for eleven patents. For his contributions to medicine, Dr. Woosley has received numerous awards from academic institutions, the Food and Drug Administration and professional societies.